Innovation and Entrepreneurship

Innovation

Office of Innovation and Entrepreneurship

Commercialise your research or work

Technology commercialisation is the process of developing an invention or idea into a new product or service that enters the health or life science market.

Strategic Priorities

Be a gold-standard innovation and commercialisation enterprise.
Build a diverse innovation portfolio and community.
Be a market partner of choice.
Grow a vibrant and inclusive ecosystem.
Train innovators and entrepreneurs.
Tell the stories of our impact.

Message from the Vice-Dean

To innovate is a fundamental aspiration for institutions of higher learning in Singapore and around the world. For Duke-NUS, an invention-driven, research-intensive medical school, innovation means turning scientific discoveries into real-world applications that advance the practice of medicine and improve the health of patients and the community.

At the Office of Innovation and Entrepreneurship, three key practices help to translate discoveries from “bench to bedside”:

1) Commercialising our researchers’ inventions or contributing their unique expertise to developing and validating new therapies, diagnostics, vaccines, digital tools and medical devices.

2) Training young and aspiring health and life sciences inventors and entrepreneurs while nurturing our academic innovation community. Merging evidence-based medicine and science with commercialisation knowledge and the creativity to imagine the future of health.

3) Cultivating a health and life sciences innovation ecosystem that includes the expertise, resources, and funding needed to advance ideas from the lab into the health system and community. Essential to this are the partnerships we’ve forged with academic partners, investors, entrepreneurs, and companies.

By having a dedicated innovation office at Duke-NUS, we position the development of new modalities for health as a fundamental component of the School’s mission.

To date, Duke-NUS’ innovation and entrepreneurship activities have led to the development of new interventions including novel therapies and medical devices, new vaccines and diagnostic kits, artificial intelligence and data analytics solutions for health, and a new generation of researchers and clinical innovators who will lead the way in the advancement of medical practice and health in Singapore and around the world.

I am excited by the strength of entrepreneurship at our School in translating cutting-edge, early-stage discoveries into clinical solutions and I look forward to creating new and even closer partnerships with ecosystem partners as we work towards delivering innovations for better health.

Christopher Laing

Vice-Dean for Innovation and Entrepreneurship, Duke-NUS

Vision

Duke-NUS is known globally for the real-world impact of its research, education, and academic medicine.

Mission

Enable Duke-NUS and AMC health technologies, expertise, and research capabilities to be developed with commercial partners for the benefit of patients and the community.

At Duke-NUS, we encourage our researchers to push the envelope in pursuing bench-to-bedside research, translating scientific discoveries into products or services that may one day be deployed in the clinic or in the community.

For our researchers

Close collaborations with industry partners are a key enabler to bench-to-bedside innovation. We are committed to forging collaborations with like-minded partners to accelerate the translation of research into real-world solutions.

For collaborators